ERIN HEGGE: Open Payments
NPI 1609894344 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,092 in 107 payments from 17 companies in 2025. Trend: 2023 $1,814 · 2024 $1,766 · 2025 $2,092
Food & beverage: $1,992Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $343 |
| Lilly USA, LLC | 24 | $317 |
| Novartis Pharmaceuticals Corporation | 13 | $230 |
| GENZYME CORPORATION | 9 | $227 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $162 |
| Organon LLC | 5 | $157 |
| Incyte Corporation | 4 | $130 |
| Abbott Laboratories | 1 | $109 |
| Botanix SB Inc | 4 | $77 |
| Amgen Inc. | 3 | $74 |
Products named: TALTZ, RINVOQ, COSENTYX, VTAMA, SKYRIZI, DUPIXENT, OPZELURA, PROCLAIM.
Industry payments across NE — which companies pay providers there.
